Long-term prophylaxis for hereditary angioedema: Initial experiences with garadacimab and lanadelumab by Jane C.Y. Wong, MBBS, FHKCP, Valerie Chiang, MBBS, Dorothy L.Y. Lam, MSc, Elaine Lee, MSc, Ki Lam, MBBS, FRCPA, Elaine Y.L. Au, FRCPA, FHKCPath, Philip H. Li, MD, FRCP

Get full text